On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma.
Ribatti
D
D
Vacca
A
A
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D009101:Multiple Myeloma / Q000098:blood supply* / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide